Novel motif:62
From FANTOM5_SSTAR
name: | motif62_CGNGAT |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0050434 | positive regulation of viral transcription | 2.989934e-16 |
GO:0046782 | regulation of viral transcription | 1.402937e-15 |
GO:0006353 | transcription termination, DNA-dependent | 3.413784e-11 |
GO:0048524 | positive regulation of viral reproduction | 3.708896e-11 |
GO:0006396 | RNA processing | 1.418534e-9 |
GO:0006281 | DNA repair | 1.480426e-9 |
GO:0009452 | RNA capping | 3.497333e-9 |
GO:0000398 | nuclear mRNA splicing, via spliceosome | 7.244431e-9 |
GO:0000375 | RNA splicing, via transesterification reactions | 7.428532e-9 |
GO:0015820 | leucine transport | 1.674365e-8 |
GO:0006370 | mRNA capping | 3.730399e-8 |
GO:0043923 | positive regulation by host of viral transcription | 5.774953e-8 |
GO:0051131 | chaperone-mediated protein complex assembly | 6.058705e-8 |
GO:0008033 | tRNA processing | 7.900102e-8 |
GO:0043921 | modulation by host of viral transcription | 1.380918e-7 |
GO:0031055 | chromatin remodeling at centromere | 1.905805e-7 |
GO:0045040 | protein import into mitochondrial outer membrane | 1.936349e-7 |
GO:0006308 | DNA catabolic process | 2.344500e-7 |
GO:2000119 | negative regulation of sodium-dependent phosphate transport | 2.380043e-7 |
GO:0034080 | CenH3-containing nucleosome assembly at centromere | 2.416979e-7 |
GO:0052312 | modulation of transcription in other organism involved in symbiotic interaction | 2.488795e-7 |
GO:0006369 | termination of RNA polymerase II transcription | 2.748308e-7 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 3.027250e-7 |
GO:0060356 | leucine import | 3.192732e-7 |
GO:0006366 | transcription from RNA polymerase II promoter | 3.957628e-7 |
GO:0043044 | ATP-dependent chromatin remodeling | 7.958788e-7 |
GO:0015827 | tryptophan transport | 8.712376e-7 |
GO:0043486 | histone exchange | 9.382158e-7 |
GO:0045606 | positive regulation of epidermal cell differentiation | 1.240268e-6 |
GO:0008380 | RNA splicing | 1.293023e-6 |
GO:0010835 | regulation of protein ADP-ribosylation | 1.830323e-6 |
GO:0071422 | succinate transmembrane transport | 2.371033e-6 |
GO:0031860 | telomeric 3' overhang formation | 3.495238e-6 |
GO:0032042 | mitochondrial DNA metabolic process | 3.518198e-6 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 4.139603e-6 |
GO:0032312 | regulation of ARF GTPase activity | 8.150996e-6 |
GO:0006414 | translational elongation | 9.794030e-6 |
GO:0015742 | alpha-ketoglutarate transport | 9.807854e-6 |
GO:0034498 | early endosome to Golgi transport | 1.060283e-5 |
GO:0018350 | protein esterification | 1.077847e-5 |
GO:0044258 | intestinal lipid catabolic process | 1.077847e-5 |
GO:0007339 | binding of sperm to zona pellucida | 1.091107e-5 |
GO:0097151 | positive regulation of inhibitory postsynaptic membrane potential | 1.234101e-5 |
GO:0006363 | termination of RNA polymerase I transcription | 1.315701e-5 |
GO:0006264 | mitochondrial DNA replication | 1.438738e-5 |
GO:0016032 | viral reproduction | 1.472161e-5 |
GO:0006354 | transcription elongation, DNA-dependent | 1.616396e-5 |
GO:0050792 | regulation of viral reproduction | 1.913816e-5 |
GO:0007141 | male meiosis I | 1.920127e-5 |
GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.137348e-5 |
GO:0034470 | ncRNA processing | 2.143346e-5 |
GO:0034619 | cellular chaperone-mediated protein complex assembly | 2.153727e-5 |
GO:0042946 | glucoside transport | 2.188352e-5 |
GO:0061360 | optic chiasma development | 2.196006e-5 |
GO:2000597 | positive regulation of optic nerve formation | 2.196006e-5 |
GO:0035799 | ureter maturation | 2.196006e-5 |
GO:0021650 | vestibulocochlear nerve formation | 2.196006e-5 |
GO:0021633 | optic nerve structural organization | 2.196006e-5 |
GO:0003406 | retinal pigment epithelium development | 2.275641e-5 |
GO:0006513 | protein monoubiquitination | 2.511863e-5 |
GO:0006054 | N-acetylneuraminate metabolic process | 2.564891e-5 |
GO:0006427 | histidyl-tRNA aminoacylation | 2.837522e-5 |
GO:0010509 | polyamine homeostasis | 2.837522e-5 |
GO:0016048 | detection of temperature stimulus | 3.059741e-5 |
GO:0042360 | vitamin E metabolic process | 3.206759e-5 |
GO:0060689 | cell differentiation involved in salivary gland development | 3.265551e-5 |
GO:0090140 | regulation of mitochondrial fission | 3.265551e-5 |
GO:0051534 | negative regulation of NFAT protein import into nucleus | 3.280007e-5 |
GO:0006289 | nucleotide-excision repair | 3.423071e-5 |
GO:2000378 | negative regulation of reactive oxygen species metabolic process | 3.469512e-5 |
GO:0021603 | cranial nerve formation | 3.627543e-5 |
GO:0042407 | cristae formation | 3.829413e-5 |
GO:0019428 | allantoin biosynthetic process | 3.829413e-5 |
GO:0033687 | osteoblast proliferation | 4.425414e-5 |
GO:0006361 | transcription initiation from RNA polymerase I promoter | 4.449908e-5 |
GO:0090304 | nucleic acid metabolic process | 4.847194e-5 |
GO:0035036 | sperm-egg recognition | 5.083480e-5 |
GO:0045900 | negative regulation of translational elongation | 5.277872e-5 |
GO:0016071 | mRNA metabolic process | 5.755991e-5 |
GO:0010467 | gene expression | 6.307060e-5 |
GO:0006259 | DNA metabolic process | 6.798654e-5 |
GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein | 7.036972e-5 |
GO:0031914 | negative regulation of synaptic plasticity | 7.743951e-5 |
GO:0048291 | isotype switching to IgG isotypes | 7.831508e-5 |
GO:0015709 | thiosulfate transport | 7.831508e-5 |
GO:0071423 | malate transmembrane transport | 7.831508e-5 |
GO:0002842 | positive regulation of T cell mediated immune response to tumor cell | 7.831508e-5 |
GO:0002368 | B cell cytokine production | 7.831508e-5 |
GO:0006333 | chromatin assembly or disassembly | 8.190693e-5 |
GO:0006383 | transcription from RNA polymerase III promoter | 9.221481e-5 |
GO:0060318 | definitive erythrocyte differentiation | 9.773195e-5 |
GO:0002679 | respiratory burst involved in defense response | 1.032966e-4 |
GO:0016140 | O-glycoside metabolic process | 1.109572e-4 |
GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine | 1.134077e-4 |
GO:0006782 | protoporphyrinogen IX biosynthetic process | 1.262769e-4 |
GO:0060580 | ventral spinal cord interneuron fate determination | 1.285500e-4 |
GO:0003327 | type B pancreatic cell fate commitment | 1.285500e-4 |
GO:2000465 | regulation of glycogen (starch) synthase activity | 1.432073e-4 |
GO:0021559 | trigeminal nerve development | 1.462374e-4 |
GO:0006412 | translation | 1.704569e-4 |
GO:0000080 | G1 phase of mitotic cell cycle | 1.711007e-4 |
GO:0070934 | CRD-mediated mRNA stabilization | 1.746274e-4 |
GO:0030208 | dermatan sulfate biosynthetic process | 1.770651e-4 |
GO:0007199 | G-protein signaling, coupled to cGMP nucleotide second messenger | 1.772609e-4 |
GO:0030322 | stabilization of membrane potential | 1.877347e-4 |
GO:0009107 | lipoate biosynthetic process | 1.877347e-4 |
GO:0072553 | terminal button organization | 1.932510e-4 |
GO:0000088 | mitotic prophase | 1.932510e-4 |
GO:0051984 | positive regulation of chromosome segregation | 1.932510e-4 |
GO:0035621 | ER to Golgi ceramide transport | 1.932510e-4 |
GO:0006867 | asparagine transport | 1.932510e-4 |
GO:0060836 | lymphatic endothelial cell differentiation | 2.081068e-4 |
GO:0032298 | positive regulation of DNA-dependent DNA replication initiation | 2.102632e-4 |
GO:0003157 | endocardium development | 2.124167e-4 |
GO:0071281 | cellular response to iron ion | 2.167053e-4 |
GO:0006984 | ER-nucleus signaling pathway | 2.189378e-4 |
GO:0006457 | protein folding | 2.194336e-4 |
GO:0046022 | positive regulation of transcription from RNA polymerase II promoter during mitosis | 2.258395e-4 |
GO:0008052 | sensory organ boundary specification | 2.303482e-4 |
GO:0015801 | aromatic amino acid transport | 2.313291e-4 |
GO:0008272 | sulfate transport | 2.315746e-4 |
GO:0050435 | beta-amyloid metabolic process | 2.377282e-4 |
GO:0046521 | sphingoid catabolic process | 2.377282e-4 |
GO:0006094 | gluconeogenesis | 2.434425e-4 |
GO:0006399 | tRNA metabolic process | 2.438808e-4 |
GO:0021562 | vestibulocochlear nerve development | 2.486047e-4 |
GO:0072162 | metanephric mesenchymal cell differentiation | 2.544566e-4 |
GO:0051340 | regulation of ligase activity | 2.559846e-4 |
GO:0016070 | RNA metabolic process | 2.565910e-4 |
GO:0042797 | tRNA transcription from RNA polymerase III promoter | 2.670251e-4 |
GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter | 2.670251e-4 |
GO:0009200 | deoxyribonucleoside triphosphate metabolic process | 2.685021e-4 |
GO:0021932 | hindbrain radial glia guided cell migration | 2.690042e-4 |
GO:0060056 | mammary gland involution | 2.771461e-4 |
GO:0016574 | histone ubiquitination | 2.841929e-4 |
GO:0009262 | deoxyribonucleotide metabolic process | 3.169820e-4 |
GO:0051028 | mRNA transport | 3.555820e-4 |
GO:0060577 | pulmonary vein morphogenesis | 3.740341e-4 |
GO:0035922 | foramen ovale closure | 3.740341e-4 |
GO:0003193 | pulmonary valve formation | 3.740341e-4 |
GO:0031627 | telomeric loop formation | 3.740341e-4 |
GO:0006362 | transcription elongation from RNA polymerase I promoter | 3.762624e-4 |
GO:0048103 | somatic stem cell division | 3.862295e-4 |
GO:0006397 | mRNA processing | 4.052053e-4 |
GO:0071864 | positive regulation of cell proliferation in bone marrow | 4.073395e-4 |
GO:0071866 | negative regulation of apoptosis in bone marrow | 4.073395e-4 |
GO:0014916 | regulation of lung blood pressure | 4.192227e-4 |
GO:2000466 | negative regulation of glycogen (starch) synthase activity | 4.353124e-4 |
GO:0055026 | negative regulation of cardiac muscle tissue development | 4.353124e-4 |
GO:0070544 | histone H3-K36 demethylation | 4.361153e-4 |
GO:0006103 | 2-oxoglutarate metabolic process | 4.370832e-4 |
GO:0007023 | post-chaperonin tubulin folding pathway | 4.521065e-4 |
GO:0010756 | positive regulation of plasminogen activation | 4.572556e-4 |
GO:0061050 | regulation of cell growth involved in cardiac muscle cell development | 4.739492e-4 |
GO:0032922 | circadian regulation of gene expression | 4.757071e-4 |
GO:0034976 | response to endoplasmic reticulum stress | 4.776531e-4 |
GO:0008049 | male courtship behavior | 4.800041e-4 |
GO:0033260 | DNA replication involved in S phase | 4.800041e-4 |
GO:0042450 | arginine biosynthetic process via ornithine | 4.800041e-4 |
GO:0010734 | negative regulation of protein glutathionylation | 4.800041e-4 |
GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade | 5.080251e-4 |
GO:0007080 | mitotic metaphase plate congression | 5.269454e-4 |
GO:0009060 | aerobic respiration | 5.355204e-4 |
GO:0090141 | positive regulation of mitochondrial fission | 5.356502e-4 |
GO:0009304 | tRNA transcription | 5.424291e-4 |
GO:0035305 | negative regulation of dephosphorylation | 5.565724e-4 |
GO:0021678 | third ventricle development | 5.665918e-4 |
GO:0006302 | double-strand break repair | 5.730394e-4 |
GO:0019319 | hexose biosynthetic process | 5.979629e-4 |
GO:0006102 | isocitrate metabolic process | 6.253221e-4 |
GO:0001757 | somite specification | 6.253221e-4 |
GO:0021943 | formation of radial glial scaffolds | 6.417231e-4 |
GO:0060839 | endothelial cell fate commitment | 6.431885e-4 |
GO:0046853 | inositol or phosphatidylinositol phosphorylation | 6.502461e-4 |
GO:0035566 | regulation of metanephros size | 6.521923e-4 |
GO:0006476 | protein deacetylation | 6.626181e-4 |
GO:0035601 | protein deacylation | 6.687605e-4 |
GO:2000243 | positive regulation of reproductive process | 6.993590e-4 |
GO:0072300 | positive regulation of metanephric glomerulus development | 7.047022e-4 |
GO:0046796 | viral genome transport in host cell | 7.299758e-4 |
GO:0050666 | regulation of homocysteine metabolic process | 7.342943e-4 |
GO:0016570 | histone modification | 7.372195e-4 |
GO:0016577 | histone demethylation | 7.406735e-4 |
GO:0046778 | modification by virus of host mRNA processing | 7.825323e-4 |
GO:0009440 | cyanate catabolic process | 7.825323e-4 |
GO:0006783 | heme biosynthetic process | 8.009547e-4 |
GO:0006554 | lysine catabolic process | 8.026613e-4 |
GO:0006400 | tRNA modification | 8.091610e-4 |
GO:0090002 | establishment of protein localization in plasma membrane | 8.317896e-4 |
GO:0002149 | hypochlorous acid biosynthetic process | 8.553962e-4 |
GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair | 8.694050e-4 |
GO:0050965 | detection of temperature stimulus involved in sensory perception of pain | 8.694050e-4 |
GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development | 9.270765e-4 |
GO:0016142 | O-glycoside catabolic process | 9.270765e-4 |
GO:0003061 | positive regulation of the force of heart contraction by norepinephrine | 9.270765e-4 |
GO:0001514 | selenocysteine incorporation | 9.625493e-4 |
GO:0031497 | chromatin assembly | 9.663164e-4 |
GO:0071899 | negative regulation of estrogen receptor binding | 9.904195e-4 |
GO:0009068 | aspartate family amino acid catabolic process | 1.035670e-3 |
GO:0090212 | negative regulation of establishment of blood-brain barrier | 1.038240e-3 |
GO:0009301 | snRNA transcription | 1.060620e-3 |
GO:0034637 | cellular carbohydrate biosynthetic process | 1.113949e-3 |
GO:0050668 | positive regulation of homocysteine metabolic process | 1.120138e-3 |
GO:0045963 | negative regulation of dopamine metabolic process | 1.120138e-3 |
GO:0035522 | monoubiquitinated histone H2A deubiquitination | 1.120138e-3 |
GO:0045931 | positive regulation of mitotic cell cycle | 1.127219e-3 |
GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway | 1.131792e-3 |
GO:0010189 | vitamin E biosynthetic process | 1.131792e-3 |
GO:0000492 | box C/D snoRNP assembly | 1.143668e-3 |
GO:0051204 | protein insertion into mitochondrial membrane | 1.145658e-3 |
GO:0070253 | somatostatin secretion | 1.149486e-3 |
GO:0019556 | histidine catabolic process to glutamate and formamide | 1.149486e-3 |
GO:0032812 | positive regulation of epinephrine secretion | 1.149486e-3 |
GO:0002121 | inter-male aggressive behavior | 1.178974e-3 |
GO:0033083 | regulation of immature T cell proliferation | 1.217138e-3 |
GO:0045604 | regulation of epidermal cell differentiation | 1.306258e-3 |
GO:0006415 | translational termination | 1.318266e-3 |
GO:0000718 | nucleotide-excision repair, DNA damage removal | 1.362174e-3 |
GO:0060690 | epithelial cell differentiation involved in salivary gland development | 1.415293e-3 |
GO:0003184 | pulmonary valve morphogenesis | 1.415293e-3 |
GO:0010626 | negative regulation of Schwann cell proliferation | 1.467920e-3 |
GO:0034259 | negative regulation of Rho GTPase activity | 1.485895e-3 |
GO:0046501 | protoporphyrinogen IX metabolic process | 1.501227e-3 |
GO:0051318 | G1 phase | 1.515335e-3 |
GO:0003148 | outflow tract septum morphogenesis | 1.525371e-3 |
GO:0051156 | glucose 6-phosphate metabolic process | 1.541505e-3 |
GO:0007051 | spindle organization | 1.591126e-3 |
GO:0031507 | heterochromatin formation | 1.607414e-3 |
GO:0006235 | dTTP biosynthetic process | 1.660902e-3 |
GO:0034551 | mitochondrial respiratory chain complex III assembly | 1.660902e-3 |
GO:0021535 | cell migration in hindbrain | 1.710251e-3 |
GO:0042375 | quinone cofactor metabolic process | 1.736368e-3 |
GO:0051438 | regulation of ubiquitin-protein ligase activity | 1.743869e-3 |
GO:0021592 | fourth ventricle development | 1.748561e-3 |
GO:0009103 | lipopolysaccharide biosynthetic process | 1.752543e-3 |
GO:0016569 | covalent chromatin modification | 1.820816e-3 |
GO:0031017 | exocrine pancreas development | 1.839536e-3 |
GO:0006482 | protein demethylation | 1.841922e-3 |
GO:0009650 | UV protection | 1.861126e-3 |
GO:0072661 | protein targeting to plasma membrane | 1.861495e-3 |
GO:0050658 | RNA transport | 1.903038e-3 |
GO:0000738 | DNA catabolic process, exonucleolytic | 1.931449e-3 |
GO:0001522 | pseudouridine synthesis | 1.931449e-3 |
GO:0051851 | modification by host of symbiont morphology or physiology | 1.998760e-3 |
GO:0045063 | T-helper 1 cell differentiation | 2.018533e-3 |
GO:0051351 | positive regulation of ligase activity | 2.069067e-3 |
GO:0042168 | heme metabolic process | 2.078853e-3 |
GO:0032446 | protein modification by small protein conjugation | 2.083755e-3 |
GO:0070170 | regulation of tooth mineralization | 2.100578e-3 |
GO:0006403 | RNA localization | 2.196224e-3 |
GO:0003057 | regulation of the force of heart contraction by chemical signal | 2.235515e-3 |
GO:0060214 | endocardium formation | 2.253617e-3 |
GO:0030237 | female sex determination | 2.263422e-3 |
GO:0030683 | evasion by virus of host immune response | 2.323514e-3 |
GO:0021568 | rhombomere 2 development | 2.365719e-3 |
GO:0006432 | phenylalanyl-tRNA aminoacylation | 2.365719e-3 |
GO:0001844 | protein insertion into mitochondrial membrane involved in induction of apoptosis | 2.369911e-3 |
GO:0034660 | ncRNA metabolic process | 2.415029e-3 |
GO:0045660 | positive regulation of neutrophil differentiation | 2.415759e-3 |
GO:0010966 | regulation of phosphate transport | 2.424023e-3 |
GO:0048313 | Golgi inheritance | 2.428070e-3 |
GO:0010727 | negative regulation of hydrogen peroxide metabolic process | 2.428070e-3 |
GO:0051457 | maintenance of protein location in nucleus | 2.437923e-3 |
GO:0070972 | protein localization in endoplasmic reticulum | 2.531719e-3 |
GO:0032469 | endoplasmic reticulum calcium ion homeostasis | 2.545502e-3 |
GO:0021506 | anterior neuropore closure | 2.620664e-3 |
GO:0046364 | monosaccharide biosynthetic process | 2.677163e-3 |
GO:0060711 | labyrinthine layer development | 2.694792e-3 |
GO:0002071 | glandular epithelial cell maturation | 2.706377e-3 |
GO:0043089 | positive regulation of Cdc42 GTPase activity | 2.740546e-3 |
GO:0031468 | nuclear envelope reassembly | 2.763932e-3 |
GO:0032864 | activation of Cdc42 GTPase activity | 2.770992e-3 |
GO:0071469 | cellular response to alkalinity | 2.809170e-3 |
GO:0071283 | cellular response to iron(III) ion | 2.809170e-3 |
GO:2000009 | negative regulation of protein localization at cell surface | 2.809170e-3 |
GO:0046380 | N-acetylneuraminate biosynthetic process | 2.809170e-3 |
GO:0046680 | response to DDT | 2.809170e-3 |
GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore | 2.809170e-3 |
GO:0060623 | regulation of chromosome condensation | 2.809170e-3 |
GO:0060708 | spongiotrophoblast differentiation | 2.814824e-3 |
GO:0021930 | cerebellar granule cell precursor proliferation | 2.834863e-3 |
GO:0016567 | protein ubiquitination | 2.845645e-3 |
GO:0021903 | rostrocaudal neural tube patterning | 2.933376e-3 |
GO:0048793 | pronephros development | 2.948492e-3 |
GO:0016051 | carbohydrate biosynthetic process | 3.018397e-3 |
GO:0006360 | transcription from RNA polymerase I promoter | 3.071186e-3 |
GO:0007341 | penetration of zona pellucida | 3.117377e-3 |
GO:2000241 | regulation of reproductive process | 3.180157e-3 |
GO:0006297 | nucleotide-excision repair, DNA gap filling | 3.180516e-3 |
GO:0000723 | telomere maintenance | 3.210882e-3 |
GO:0002067 | glandular epithelial cell differentiation | 3.211449e-3 |
GO:0072595 | maintenance of protein localization to organelle | 3.216767e-3 |
GO:0006983 | ER overload response | 3.333114e-3 |
GO:0071514 | genetic imprinting | 3.391546e-3 |
GO:0070194 | synaptonemal complex disassembly | 3.407169e-3 |
GO:0060339 | negative regulation of type I interferon-mediated signaling pathway | 3.407169e-3 |
GO:0031662 | positive regulation of cyclin-dependent protein kinase activity involved in G2/M | 3.407169e-3 |
GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development | 3.433033e-3 |
GO:0034728 | nucleosome organization | 3.473595e-3 |
GO:0061384 | heart trabecular morphogenesis | 3.484765e-3 |
GO:0043586 | tongue development | 3.508827e-3 |
GO:0044240 | multicellular organismal lipid catabolic process | 3.573628e-3 |
GO:0006610 | ribosomal protein import into nucleus | 3.601026e-3 |
GO:0015936 | coenzyme A metabolic process | 3.623631e-3 |
GO:0060849 | regulation of transcription involved in lymphatic endothelial cell fate commitment | 3.625593e-3 |
GO:0030852 | regulation of granulocyte differentiation | 3.684437e-3 |
GO:0035166 | post-embryonic hemopoiesis | 3.733444e-3 |
GO:0043558 | regulation of translational initiation in response to stress | 3.733444e-3 |
GO:0033088 | negative regulation of immature T cell proliferation in thymus | 3.733444e-3 |
GO:0006458 | 'de novo' protein folding | 3.766918e-3 |
GO:0010070 | zygote asymmetric cell division | 3.792631e-3 |
GO:0034227 | tRNA thio-modification | 3.795388e-3 |
GO:0002098 | tRNA wobble uridine modification | 3.795388e-3 |
GO:0009298 | GDP-mannose biosynthetic process | 3.795388e-3 |
GO:0071895 | odontoblast differentiation | 3.812837e-3 |
GO:0045047 | protein targeting to ER | 3.829529e-3 |
GO:0072148 | epithelial cell fate commitment | 3.831394e-3 |
GO:0070925 | organelle assembly | 3.856347e-3 |
GO:0006552 | leucine catabolic process | 3.922206e-3 |
GO:0030223 | neutrophil differentiation | 3.944446e-3 |
GO:0000255 | allantoin metabolic process | 3.944446e-3 |
GO:0008156 | negative regulation of DNA replication | 3.989109e-3 |
GO:0003409 | optic cup structural organization | 4.028525e-3 |
GO:0021623 | oculomotor nerve formation | 4.028525e-3 |
GO:0003404 | optic vesicle morphogenesis | 4.028525e-3 |
GO:2000467 | positive regulation of glycogen (starch) synthase activity | 4.033594e-3 |
GO:0016226 | iron-sulfur cluster assembly | 4.043204e-3 |
GO:0045200 | establishment of neuroblast polarity | 4.176450e-3 |
GO:0043048 | dolichyl monophosphate biosynthetic process | 4.176450e-3 |
GO:0009088 | threonine biosynthetic process | 4.176450e-3 |
GO:0019236 | response to pheromone | 4.176450e-3 |
GO:0070979 | protein K11-linked ubiquitination | 4.181092e-3 |
GO:0001835 | blastocyst hatching | 4.258828e-3 |
GO:0090031 | positive regulation of steroid hormone biosynthetic process | 4.277080e-3 |
GO:0048537 | mucosal-associated lymphoid tissue development | 4.297628e-3 |
GO:0046514 | ceramide catabolic process | 4.336555e-3 |
GO:0051225 | spindle assembly | 4.432786e-3 |
GO:0043491 | protein kinase B signaling cascade | 4.448719e-3 |
GO:0010954 | positive regulation of protein processing | 4.455735e-3 |
GO:0060347 | heart trabecula formation | 4.524528e-3 |
GO:0015886 | heme transport | 4.551723e-3 |
GO:0021993 | initiation of neural tube closure | 4.666302e-3 |
GO:0051532 | regulation of NFAT protein import into nucleus | 4.671427e-3 |
GO:0046952 | ketone body catabolic process | 4.683450e-3 |
GO:0033484 | nitric oxide homeostasis | 4.743438e-3 |
GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development | 4.870393e-3 |
GO:0002092 | positive regulation of receptor internalization | 4.968385e-3 |
GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process | 4.986026e-3 |
GO:0060376 | positive regulation of mast cell differentiation | 4.986026e-3 |
GO:0048069 | eye pigmentation | 5.267420e-3 |
GO:0021631 | optic nerve morphogenesis | 5.291183e-3 |
GO:0006695 | cholesterol biosynthetic process | 5.335751e-3 |
GO:0006338 | chromatin remodeling | 5.574451e-3 |
GO:0007388 | posterior compartment specification | 5.611907e-3 |
GO:0007387 | anterior compartment pattern formation | 5.611907e-3 |
GO:0072202 | cell differentiation involved in metanephros development | 5.643505e-3 |
GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c | 5.729804e-3 |
GO:0009109 | coenzyme catabolic process | 5.748759e-3 |
GO:0015986 | ATP synthesis coupled proton transport | 5.751853e-3 |
GO:0070179 | D-serine biosynthetic process | 5.914726e-3 |
GO:0021933 | radial glia guided migration of cerebellar granule cell | 5.914726e-3 |
GO:2000725 | regulation of cardiac muscle cell differentiation | 5.976356e-3 |
GO:0021554 | optic nerve development | 5.976356e-3 |
GO:0021591 | ventricular system development | 6.048477e-3 |
GO:0006405 | RNA export from nucleus | 6.067232e-3 |
GO:0000079 | regulation of cyclin-dependent protein kinase activity | 6.082416e-3 |
GO:0006598 | polyamine catabolic process | 6.095922e-3 |
GO:0033136 | serine phosphorylation of STAT3 protein | 6.095922e-3 |
GO:0002158 | osteoclast proliferation | 6.095922e-3 |
GO:0051187 | cofactor catabolic process | 6.101422e-3 |
GO:0090150 | establishment of protein localization in membrane | 6.188389e-3 |
GO:2000369 | regulation of clathrin-mediated endocytosis | 6.200395e-3 |
GO:0017004 | cytochrome complex assembly | 6.361429e-3 |
GO:0009106 | lipoate metabolic process | 6.361429e-3 |
GO:0060301 | positive regulation of cytokine activity | 6.384445e-3 |
GO:0030520 | estrogen receptor signaling pathway | 6.477597e-3 |
GO:0070086 | ubiquitin-dependent endocytosis | 6.479184e-3 |
GO:0060691 | epithelial cell maturation involved in salivary gland development | 6.479184e-3 |
GO:0046105 | thymidine biosynthetic process | 6.479184e-3 |
GO:0060096 | serotonin secretion, neurotransmission | 6.479184e-3 |
GO:0048102 | autophagic cell death | 6.483083e-3 |
GO:0045618 | positive regulation of keratinocyte differentiation | 6.483083e-3 |
GO:0032793 | positive regulation of CREB transcription factor activity | 6.485022e-3 |
GO:0006914 | autophagy | 6.528738e-3 |
GO:0090344 | negative regulation of cell aging | 6.623656e-3 |
GO:0003099 | positive regulation of the force of heart contraction by chemical signal | 6.623656e-3 |
GO:0006244 | pyrimidine nucleotide catabolic process | 6.677011e-3 |
GO:0017196 | N-terminal peptidyl-methionine acetylation | 6.788476e-3 |
GO:0032714 | negative regulation of interleukin-5 production | 6.874399e-3 |
GO:0046833 | positive regulation of RNA export from nucleus | 6.884262e-3 |
GO:0006051 | N-acetylmannosamine metabolic process | 6.884262e-3 |
GO:0070562 | regulation of vitamin D receptor signaling pathway | 6.953108e-3 |
GO:0006097 | glyoxylate cycle | 6.953108e-3 |
GO:0061054 | dermatome development | 6.953108e-3 |
GO:0032784 | regulation of transcription elongation, DNA-dependent | 6.996757e-3 |
GO:0042026 | protein refolding | 7.571144e-3 |
GO:0045658 | regulation of neutrophil differentiation | 7.620626e-3 |
GO:0045008 | depyrimidination | 7.620626e-3 |
GO:0030853 | negative regulation of granulocyte differentiation | 7.623333e-3 |
GO:0090342 | regulation of cell aging | 7.633421e-3 |
GO:0009219 | pyrimidine deoxyribonucleotide metabolic process | 7.658401e-3 |
GO:0046732 | active induction of host immune response by virus | 7.683101e-3 |
GO:0010845 | positive regulation of reciprocal meiotic recombination | 7.727127e-3 |
GO:0016233 | telomere capping | 7.779526e-3 |
GO:0001892 | embryonic placenta development | 7.995297e-3 |
GO:0034645 | cellular macromolecule biosynthetic process | 8.067645e-3 |
GO:0033084 | regulation of immature T cell proliferation in thymus | 8.147134e-3 |
GO:0000066 | mitochondrial ornithine transport | 8.217927e-3 |
GO:0071166 | ribonucleoprotein complex localization | 8.217927e-3 |
GO:0009438 | methylglyoxal metabolic process | 8.224846e-3 |
GO:0051289 | protein homotetramerization | 8.355037e-3 |
GO:0015746 | citrate transport | 8.372768e-3 |
GO:0003329 | pancreatic PP cell fate commitment | 8.372768e-3 |
GO:0003326 | pancreatic A cell fate commitment | 8.372768e-3 |
GO:0006303 | double-strand break repair via nonhomologous end joining | 8.434972e-3 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 8.466888e-3 |
GO:0032288 | myelin assembly | 8.683014e-3 |
GO:0032471 | reduction of endoplasmic reticulum calcium ion concentration | 8.703125e-3 |
GO:0010460 | positive regulation of heart rate | 8.715268e-3 |
GO:0030157 | pancreatic juice secretion | 8.717064e-3 |
GO:0007089 | traversing start control point of mitotic cell cycle | 8.831347e-3 |
GO:0032696 | negative regulation of interleukin-13 production | 8.989687e-3 |
GO:0031396 | regulation of protein ubiquitination | 9.020110e-3 |
GO:0045014 | negative regulation of transcription by glucose | 9.038066e-3 |
GO:0045918 | negative regulation of cytolysis | 9.038066e-3 |
GO:0043153 | entrainment of circadian clock by photoperiod | 9.117031e-3 |
GO:0060712 | spongiotrophoblast layer development | 9.150863e-3 |
GO:0015780 | nucleotide-sugar transport | 9.248297e-3 |
GO:2000019 | negative regulation of male gonad development | 9.298533e-3 |
GO:2000066 | positive regulation of cortisol biosynthetic process | 9.298533e-3 |
GO:0061369 | negative regulation of testicular blood vessel morphogenesis | 9.298533e-3 |
GO:2000225 | negative regulation of testosterone biosynthetic process | 9.298533e-3 |
GO:0033080 | immature T cell proliferation in thymus | 9.298533e-3 |
GO:0002536 | respiratory burst involved in inflammatory response | 9.298533e-3 |
GO:0006408 | snRNA export from nucleus | 9.298533e-3 |
GO:0030149 | sphingolipid catabolic process | 9.400470e-3 |
GO:0035082 | axoneme assembly | 9.499542e-3 |
GO:0006356 | regulation of transcription from RNA polymerase I promoter | 9.700206e-3 |
GO:0042254 | ribosome biogenesis | 9.748155e-3 |
GO:0009648 | photoperiodism | 9.833065e-3 |
GO:0007099 | centriole replication | 9.833065e-3 |
GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion | 9.833065e-3 |
GO:0034111 | negative regulation of homotypic cell-cell adhesion | 9.878682e-3 |
GO:0009263 | deoxyribonucleotide biosynthetic process | 9.885578e-3 |
GO:0006084 | acetyl-CoA metabolic process | 9.973770e-3 |
GO:0090035 | positive regulation of cellular chaperone-mediated protein complex assembly | 1.000879e-2 |
GO:0051084 | 'de novo' posttranslational protein folding | 1.009085e-2 |
GO:0006261 | DNA-dependent DNA replication | 1.009429e-2 |
GO:0006285 | base-excision repair, AP site formation | 1.009927e-2 |
GO:0051702 | interaction with symbiont | 1.015612e-2 |
GO:0021670 | lateral ventricle development | 1.021923e-2 |
GO:0050861 | positive regulation of B cell receptor signaling pathway | 1.037666e-2 |
GO:0048541 | Peyer's patch development | 1.054142e-2 |
GO:0032107 | regulation of response to nutrient levels | 1.059493e-2 |
GO:0016266 | O-glycan processing | 1.061040e-2 |
GO:0046416 | D-amino acid metabolic process | 1.061040e-2 |
GO:0010430 | fatty acid omega-oxidation | 1.061040e-2 |
GO:0006409 | tRNA export from nucleus | 1.061040e-2 |
GO:0060125 | negative regulation of growth hormone secretion | 1.061523e-2 |
GO:0051463 | negative regulation of cortisol secretion | 1.061523e-2 |
GO:0032328 | alanine transport | 1.066227e-2 |
GO:0010760 | negative regulation of macrophage chemotaxis | 1.067997e-2 |
GO:0034162 | toll-like receptor 9 signaling pathway | 1.067997e-2 |
GO:0000012 | single strand break repair | 1.104636e-2 |
GO:0009303 | rRNA transcription | 1.104806e-2 |
GO:0021873 | forebrain neuroblast division | 1.135677e-2 |
GO:0032480 | negative regulation of type I interferon production | 1.140774e-2 |
GO:0051320 | S phase | 1.146353e-2 |
GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis | 1.150750e-2 |
GO:2000791 | negative regulation of mesenchymal cell proliferation involved in lung development | 1.150750e-2 |
GO:0021740 | principal sensory nucleus of trigeminal nerve development | 1.150750e-2 |
GO:0061141 | lung ciliated cell differentiation | 1.150750e-2 |
GO:0000726 | non-recombinational repair | 1.164745e-2 |
GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter | 1.188164e-2 |
GO:0003065 | positive regulation of heart rate by epinephrine | 1.198052e-2 |
GO:0060236 | regulation of mitotic spindle organization | 1.198052e-2 |
GO:0019934 | cGMP-mediated signaling | 1.212419e-2 |
GO:0032717 | negative regulation of interleukin-8 production | 1.220833e-2 |
GO:0016568 | chromatin modification | 1.237640e-2 |
GO:0060177 | regulation of angiotensin metabolic process | 1.242604e-2 |
GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway | 1.248514e-2 |
GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine | 1.260841e-2 |
GO:0000917 | barrier septum formation | 1.289426e-2 |
GO:0071167 | ribonucleoprotein complex import into nucleus | 1.289426e-2 |
GO:0051443 | positive regulation of ubiquitin-protein ligase activity | 1.298175e-2 |
GO:0009956 | radial pattern formation | 1.306616e-2 |
GO:0006534 | cysteine metabolic process | 1.308696e-2 |
GO:0061205 | paramesonephric duct development | 1.317851e-2 |
GO:0031643 | positive regulation of myelination | 1.317851e-2 |
GO:0043922 | negative regulation by host of viral transcription | 1.326665e-2 |
GO:0030825 | positive regulation of cGMP metabolic process | 1.326665e-2 |
GO:0019083 | viral transcription | 1.342171e-2 |
GO:0016137 | glycoside metabolic process | 1.350354e-2 |
GO:0000731 | DNA synthesis involved in DNA repair | 1.350354e-2 |
GO:0000380 | alternative nuclear mRNA splicing, via spliceosome | 1.350354e-2 |
GO:0000212 | meiotic spindle organization | 1.350354e-2 |
GO:0031397 | negative regulation of protein ubiquitination | 1.353145e-2 |
GO:0006974 | response to DNA damage stimulus | 1.354466e-2 |
GO:0008216 | spermidine metabolic process | 1.362908e-2 |
GO:2000691 | negative regulation of cardiac muscle cell myoblast differentiation | 1.362908e-2 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0007076 | mitotic chromosome condensation | 8.007810e-10 |
GO:0008380 | RNA splicing | 2.178721e-9 |
GO:2000078 | positive regulation of type B pancreatic cell development | 4.905474e-9 |
GO:0007067 | mitosis | 1.440211e-8 |
GO:0000087 | M phase of mitotic cell cycle | 2.341417e-8 |
GO:0051276 | chromosome organization | 9.108922e-8 |
GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity | 1.241346e-7 |
GO:0061084 | negative regulation of protein refolding | 1.299751e-7 |
GO:0031577 | spindle checkpoint | 1.441068e-7 |
GO:0006397 | mRNA processing | 1.711901e-7 |
GO:0071169 | establishment of protein localization to chromatin | 1.908780e-7 |
GO:0048285 | organelle fission | 3.039886e-7 |
GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation | 3.646762e-7 |
GO:0000279 | M phase | 3.829998e-7 |
GO:0061181 | regulation of chondrocyte development | 8.582726e-7 |
GO:0000278 | mitotic cell cycle | 1.203569e-6 |
GO:0022403 | cell cycle phase | 1.502671e-6 |
GO:0006260 | DNA replication | 1.546124e-6 |
GO:0000724 | double-strand break repair via homologous recombination | 2.621096e-6 |
GO:0000070 | mitotic sister chromatid segregation | 3.934882e-6 |
GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 5.532099e-6 |
GO:0010918 | positive regulation of mitochondrial membrane potential | 5.617346e-6 |
GO:0046931 | pore complex assembly | 5.908980e-6 |
GO:0000725 | recombinational repair | 6.038681e-6 |
GO:0009107 | lipoate biosynthetic process | 6.169023e-6 |
GO:0006323 | DNA packaging | 6.313478e-6 |
GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity | 6.880263e-6 |
GO:0022417 | protein maturation by protein folding | 6.880263e-6 |
GO:0071173 | spindle assembly checkpoint | 7.657862e-6 |
GO:0048148 | behavioral response to cocaine | 1.225147e-5 |
GO:0006302 | double-strand break repair | 1.583447e-5 |
GO:0071103 | DNA conformation change | 1.724044e-5 |
GO:0071174 | mitotic cell cycle spindle checkpoint | 1.765273e-5 |
GO:0048793 | pronephros development | 1.984178e-5 |
GO:0000819 | sister chromatid segregation | 2.456294e-5 |
GO:0070602 | regulation of centromeric sister chromatid cohesion | 2.680877e-5 |
GO:0009106 | lipoate metabolic process | 2.812390e-5 |
GO:0030970 | retrograde protein transport, ER to cytosol | 2.812390e-5 |
GO:0021554 | optic nerve development | 3.720495e-5 |
GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase | 4.212405e-5 |
GO:0006235 | dTTP biosynthetic process | 4.212405e-5 |
GO:0035024 | negative regulation of Rho protein signal transduction | 4.485504e-5 |
GO:0046958 | nonassociative learning | 4.647804e-5 |
GO:0016071 | mRNA metabolic process | 4.837789e-5 |
GO:0033239 | negative regulation of cellular amine metabolic process | 5.035232e-5 |
GO:0043457 | regulation of cellular respiration | 5.202126e-5 |
GO:0007094 | mitotic cell cycle spindle assembly checkpoint | 5.458937e-5 |
GO:0006281 | DNA repair | 6.314914e-5 |
GO:0031914 | negative regulation of synaptic plasticity | 6.590718e-5 |
GO:0006396 | RNA processing | 7.258665e-5 |
GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus | 7.413362e-5 |
GO:0046092 | deoxycytidine metabolic process | 7.543554e-5 |
GO:0022038 | corpus callosum development | 8.225666e-5 |
GO:2000036 | regulation of stem cell maintenance | 8.425481e-5 |
GO:2000194 | regulation of female gonad development | 9.583445e-5 |
GO:0090200 | positive regulation of release of cytochrome c from mitochondria | 1.017129e-4 |
GO:0071340 | skeletal muscle nicotinic acetylcholine receptor clustering | 1.088213e-4 |
GO:0070926 | regulation of ATP:ADP antiporter activity | 1.088213e-4 |
GO:0051661 | maintenance of centrosome location | 1.088213e-4 |
GO:0046853 | inositol or phosphatidylinositol phosphorylation | 1.190954e-4 |
GO:0035372 | protein localization to microtubule | 1.252832e-4 |
GO:0071453 | cellular response to oxygen levels | 1.336298e-4 |
GO:0006476 | protein deacetylation | 1.362621e-4 |
GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis | 1.404997e-4 |
GO:0080164 | regulation of nitric oxide metabolic process | 1.447485e-4 |
GO:0042268 | regulation of cytolysis | 1.616291e-4 |
GO:0072560 | type B pancreatic cell maturation | 1.793275e-4 |
GO:0035640 | exploration behavior | 1.807076e-4 |
GO:0042473 | outer ear morphogenesis | 1.958686e-4 |
GO:0006259 | DNA metabolic process | 2.327213e-4 |
GO:0035601 | protein deacylation | 2.356030e-4 |
GO:0045919 | positive regulation of cytolysis | 2.466519e-4 |
GO:0051775 | response to redox state | 2.466519e-4 |
GO:0072161 | mesenchymal cell differentiation involved in kidney development | 2.716408e-4 |
GO:0045358 | negative regulation of interferon-beta biosynthetic process | 2.752947e-4 |
GO:0034447 | very-low-density lipoprotein particle clearance | 2.934906e-4 |
GO:0035564 | regulation of kidney size | 2.934906e-4 |
GO:0072040 | negative regulation of mesenchymal stem cell apoptosis involved in nephron morphogenesis | 2.992263e-4 |
GO:2000774 | positive regulation of cellular senescence | 3.040443e-4 |
GO:0035986 | senescence-associated heterochromatin focus formation | 3.040443e-4 |
GO:0090402 | oncogene-induced senescence | 3.040443e-4 |
GO:0072177 | mesonephric duct development | 3.190713e-4 |
GO:0007339 | binding of sperm to zona pellucida | 3.408343e-4 |
GO:0060264 | regulation of respiratory burst involved in inflammatory response | 3.927199e-4 |
GO:0043149 | stress fiber assembly | 4.084558e-4 |
GO:0043570 | maintenance of DNA repeat elements | 4.091282e-4 |
GO:0006268 | DNA unwinding involved in replication | 4.091282e-4 |
GO:0032872 | regulation of stress-activated MAPK cascade | 4.373774e-4 |
GO:0001539 | ciliary or flagellar motility | 4.384133e-4 |
GO:0000052 | citrulline metabolic process | 5.000311e-4 |
GO:0033037 | polysaccharide localization | 5.247730e-4 |
GO:0007099 | centriole replication | 5.247730e-4 |
GO:0035912 | dorsal aorta morphogenesis | 5.509716e-4 |
GO:0030038 | contractile actin filament bundle assembly | 5.509716e-4 |
GO:0007501 | mesodermal cell fate specification | 6.028355e-4 |
GO:0030261 | chromosome condensation | 6.228927e-4 |
GO:0090244 | Wnt receptor signaling pathway involved in somitogenesis | 6.390126e-4 |
GO:0006561 | proline biosynthetic process | 6.401894e-4 |
GO:0071624 | positive regulation of granulocyte chemotaxis | 6.602459e-4 |
GO:0000379 | tRNA-type intron splice site recognition and cleavage | 6.674214e-4 |
GO:0072164 | mesonephric tubule development | 6.795100e-4 |
GO:0015920 | lipopolysaccharide transport | 6.834121e-4 |
GO:2000195 | negative regulation of female gonad development | 6.834121e-4 |
GO:0071456 | cellular response to hypoxia | 6.901246e-4 |
GO:0032049 | cardiolipin biosynthetic process | 6.986835e-4 |
GO:0006974 | response to DNA damage stimulus | 7.229533e-4 |
GO:0001829 | trophectodermal cell differentiation | 7.394118e-4 |
GO:0001823 | mesonephros development | 8.045769e-4 |
GO:0072162 | metanephric mesenchymal cell differentiation | 8.091622e-4 |
GO:0060124 | positive regulation of growth hormone secretion | 8.091622e-4 |
GO:2000054 | negative regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification | 8.091622e-4 |
GO:0010900 | negative regulation of phosphatidylcholine catabolic process | 8.091622e-4 |
GO:0009082 | branched chain family amino acid biosynthetic process | 8.091622e-4 |
GO:0033601 | positive regulation of mammary gland epithelial cell proliferation | 8.091622e-4 |
GO:0010822 | positive regulation of mitochondrion organization | 8.197878e-4 |
GO:0090343 | positive regulation of cell aging | 9.033130e-4 |
GO:0072178 | nephric duct morphogenesis | 9.279380e-4 |
GO:0070172 | positive regulation of tooth mineralization | 9.304944e-4 |
GO:0006560 | proline metabolic process | 9.304944e-4 |
GO:0051301 | cell division | 9.338683e-4 |
GO:0072194 | kidney smooth muscle tissue development | 9.456750e-4 |
GO:0070303 | negative regulation of stress-activated protein kinase signaling cascade | 9.699679e-4 |
GO:0007049 | cell cycle | 1.006557e-3 |
GO:0035036 | sperm-egg recognition | 1.014185e-3 |
GO:0021631 | optic nerve morphogenesis | 1.038243e-3 |
GO:0072205 | metanephric collecting duct development | 1.042002e-3 |
GO:0060993 | kidney morphogenesis | 1.099491e-3 |
GO:0001825 | blastocyst formation | 1.109523e-3 |
GO:0008629 | induction of apoptosis by intracellular signals | 1.145112e-3 |
GO:0022402 | cell cycle process | 1.145420e-3 |
GO:0071071 | regulation of phospholipid biosynthetic process | 1.181770e-3 |
GO:0072171 | mesonephric tubule morphogenesis | 1.206385e-3 |
GO:0042501 | serine phosphorylation of STAT protein | 1.208252e-3 |
GO:2000384 | negative regulation of ectoderm development | 1.248091e-3 |
GO:0072125 | negative regulation of glomerular mesangial cell proliferation | 1.264606e-3 |
GO:0007402 | ganglion mother cell fate determination | 1.319794e-3 |
GO:0008052 | sensory organ boundary specification | 1.319794e-3 |
GO:0016925 | protein sumoylation | 1.320462e-3 |
GO:0001504 | neurotransmitter uptake | 1.320462e-3 |
GO:0051983 | regulation of chromosome segregation | 1.357076e-3 |
GO:0034123 | positive regulation of toll-like receptor signaling pathway | 1.364584e-3 |
GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process | 1.365389e-3 |
GO:0044342 | type B pancreatic cell proliferation | 1.365389e-3 |
GO:0034259 | negative regulation of Rho GTPase activity | 1.365672e-3 |
GO:0006597 | spermine biosynthetic process | 1.365672e-3 |
GO:0072307 | regulation of metanephric nephron tubule epithelial cell differentiation | 1.413933e-3 |
GO:0000281 | cytokinesis after mitosis | 1.413933e-3 |
GO:0072172 | mesonephric tubule formation | 1.454836e-3 |
GO:0031129 | inductive cell-cell signaling | 1.504172e-3 |
GO:0021603 | cranial nerve formation | 1.562149e-3 |
GO:0072176 | nephric duct development | 1.596392e-3 |
GO:0031497 | chromatin assembly | 1.619788e-3 |
GO:0045717 | negative regulation of fatty acid biosynthetic process | 1.708665e-3 |
GO:0060123 | regulation of growth hormone secretion | 1.717851e-3 |
GO:0051318 | G1 phase | 1.750728e-3 |
GO:0046599 | regulation of centriole replication | 1.767701e-3 |
GO:0072428 | signal transduction involved in intra-S DNA damage checkpoint | 1.807655e-3 |
GO:0032532 | regulation of microvillus length | 1.807655e-3 |
GO:0018916 | nitrobenzene metabolic process | 1.807655e-3 |
GO:0002561 | basophil degranulation | 1.807655e-3 |
GO:0060997 | dendritic spine morphogenesis | 1.809377e-3 |
GO:0043687 | post-translational protein modification | 1.889625e-3 |
GO:0006658 | phosphatidylserine metabolic process | 1.889625e-3 |
GO:0072180 | mesonephric duct morphogenesis | 1.915381e-3 |
GO:0045792 | negative regulation of cell size | 1.915381e-3 |
GO:0072202 | cell differentiation involved in metanephros development | 1.968430e-3 |
GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter | 2.041900e-3 |
GO:0000910 | cytokinesis | 2.126137e-3 |
GO:0072268 | pattern specification involved in metanephros development | 2.142225e-3 |
GO:0055025 | positive regulation of cardiac muscle tissue development | 2.142225e-3 |
GO:0032048 | cardiolipin metabolic process | 2.142225e-3 |
GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 2.190959e-3 |
GO:0072133 | metanephric mesenchyme morphogenesis | 2.240621e-3 |
GO:0021545 | cranial nerve development | 2.329374e-3 |
GO:0060976 | coronary vasculature development | 2.366498e-3 |
GO:0032873 | negative regulation of stress-activated MAPK cascade | 2.405108e-3 |
GO:0070170 | regulation of tooth mineralization | 2.424388e-3 |
GO:0040040 | thermosensory behavior | 2.484691e-3 |
GO:0031440 | regulation of mRNA 3'-end processing | 2.506820e-3 |
GO:0060669 | embryonic placenta morphogenesis | 2.602142e-3 |
GO:0042989 | sequestering of actin monomers | 2.626552e-3 |
GO:0045839 | negative regulation of mitosis | 2.656471e-3 |
GO:0045922 | negative regulation of fatty acid metabolic process | 2.668035e-3 |
GO:0072124 | regulation of glomerular mesangial cell proliferation | 2.731337e-3 |
GO:0043922 | negative regulation by host of viral transcription | 2.731337e-3 |
GO:0060677 | ureteric bud elongation | 2.871128e-3 |
GO:0043526 | neuroprotection | 2.903556e-3 |
GO:0010948 | negative regulation of cell cycle process | 2.905520e-3 |
GO:2000383 | regulation of ectoderm development | 2.951270e-3 |
GO:0007168 | receptor guanylyl cyclase signaling pathway | 3.077812e-3 |
GO:0032897 | negative regulation of viral transcription | 3.164736e-3 |
GO:0046329 | negative regulation of JNK cascade | 3.214125e-3 |
GO:0007338 | single fertilization | 3.307732e-3 |
GO:0072074 | kidney mesenchyme development | 3.432317e-3 |
GO:0060689 | cell differentiation involved in salivary gland development | 3.463743e-3 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 3.653526e-3 |
GO:0032859 | activation of Ral GTPase activity | 3.795432e-3 |
GO:0072166 | posterior mesonephric tubule development | 3.810811e-3 |
GO:0048013 | ephrin receptor signaling pathway | 3.848825e-3 |
GO:0045575 | basophil activation | 3.850802e-3 |
GO:0055107 | Golgi to secretory granule transport | 3.850802e-3 |
GO:0006256 | UDP catabolic process | 3.850802e-3 |
GO:0048240 | sperm capacitation | 3.866116e-3 |
GO:0051438 | regulation of ubiquitin-protein ligase activity | 3.882605e-3 |
GO:0060696 | regulation of phospholipid catabolic process | 3.941742e-3 |
GO:0019441 | tryptophan catabolic process to kynurenine | 3.941742e-3 |
GO:0046031 | ADP metabolic process | 3.941742e-3 |
GO:0072221 | metanephric distal convoluted tubule development | 4.025505e-3 |
GO:0032423 | regulation of mismatch repair | 4.045580e-3 |
GO:0008215 | spermine metabolic process | 4.046677e-3 |
GO:0033561 | regulation of water loss via skin | 4.046677e-3 |
GO:0033136 | serine phosphorylation of STAT3 protein | 4.047429e-3 |
GO:0060266 | negative regulation of respiratory burst involved in inflammatory response | 4.047429e-3 |
GO:0018242 | protein O-linked glycosylation via serine | 4.047429e-3 |
GO:0018065 | protein-cofactor linkage | 4.047429e-3 |
GO:0018243 | protein O-linked glycosylation via threonine | 4.047429e-3 |
GO:0051482 | elevation of cytosolic calcium ion concentration involved in G-protein signaling coupled to IP3 second messenger | 4.161748e-3 |
GO:0018345 | protein palmitoylation | 4.161748e-3 |
GO:0006646 | phosphatidylethanolamine biosynthetic process | 4.202887e-3 |
GO:0051444 | negative regulation of ubiquitin-protein ligase activity | 4.205671e-3 |
GO:0030219 | megakaryocyte differentiation | 4.316852e-3 |
GO:0006661 | phosphatidylinositol biosynthetic process | 4.420345e-3 |
GO:0006403 | RNA localization | 4.577441e-3 |
GO:0072079 | nephron tubule formation | 4.595006e-3 |
GO:0072075 | metanephric mesenchyme development | 4.826469e-3 |
GO:0061015 | snRNA import into nucleus | 4.844931e-3 |
GO:0060125 | negative regulation of growth hormone secretion | 4.844931e-3 |
GO:0071217 | cellular response to external biotic stimulus | 4.844931e-3 |
GO:0034346 | positive regulation of type III interferon production | 4.844931e-3 |
GO:0045769 | negative regulation of asymmetric cell division | 4.844931e-3 |
GO:0051463 | negative regulation of cortisol secretion | 4.844931e-3 |
GO:0048659 | smooth muscle cell proliferation | 4.854393e-3 |
GO:0051340 | regulation of ligase activity | 5.012118e-3 |
GO:2000020 | positive regulation of male gonad development | 5.086020e-3 |
GO:0003148 | outflow tract septum morphogenesis | 5.131432e-3 |
GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development | 5.250424e-3 |
GO:0000492 | box C/D snoRNP assembly | 5.250424e-3 |
GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development | 5.250424e-3 |
GO:0032226 | positive regulation of synaptic transmission, dopaminergic | 5.250424e-3 |
GO:0003061 | positive regulation of the force of heart contraction by norepinephrine | 5.250424e-3 |
GO:0072305 | negative regulation of mesenchymal stem cell apoptosis involved in metanephric nephron morphogenesis | 5.290493e-3 |
GO:2000594 | positive regulation of metanephric DCT cell differentiation | 5.290493e-3 |
GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity | 5.290493e-3 |
GO:0039003 | pronephric field specification | 5.290493e-3 |
GO:0060159 | regulation of dopamine receptor signaling pathway | 5.328970e-3 |
GO:0071394 | cellular response to testosterone stimulus | 5.502843e-3 |
GO:0043666 | regulation of phosphoprotein phosphatase activity | 5.514677e-3 |
GO:0071072 | negative regulation of phospholipid biosynthetic process | 5.668885e-3 |
GO:0007062 | sister chromatid cohesion | 5.682240e-3 |
GO:0003192 | mitral valve formation | 5.714211e-3 |
GO:0032446 | protein modification by small protein conjugation | 5.783495e-3 |
GO:0043508 | negative regulation of JUN kinase activity | 5.854535e-3 |
GO:0007063 | regulation of sister chromatid cohesion | 5.854535e-3 |
GO:0000080 | G1 phase of mitotic cell cycle | 5.858600e-3 |
GO:0006325 | chromatin organization | 6.103005e-3 |
GO:2000685 | positive regulation of cellular response to X-ray | 6.106729e-3 |
GO:2001038 | regulation of cellular response to drug | 6.106729e-3 |
GO:0035988 | chondrocyte proliferation | 6.106729e-3 |
GO:2001033 | negative regulation of double-strand break repair via nonhomologous end joining | 6.106729e-3 |
GO:0003131 | mesodermal-endodermal cell signaling | 6.106729e-3 |
GO:0031052 | chromosome breakage | 6.106729e-3 |
GO:0035978 | histone H2A-S139 phosphorylation | 6.106729e-3 |
GO:0031507 | heterochromatin formation | 6.364346e-3 |
GO:0050689 | negative regulation of defense response to virus by host | 6.468404e-3 |
GO:0072179 | nephric duct formation | 6.621006e-3 |
GO:2000772 | regulation of cellular senescence | 6.684578e-3 |
GO:0043921 | modulation by host of viral transcription | 6.797747e-3 |
GO:0072098 | anterior/posterior pattern specification involved in kidney development | 6.805920e-3 |
GO:0072003 | kidney rudiment formation | 6.805920e-3 |
GO:0021562 | vestibulocochlear nerve development | 6.805920e-3 |
GO:0048389 | intermediate mesoderm development | 6.805920e-3 |
GO:0060064 | Spemann organizer formation at the anterior end of the primitive streak | 7.034182e-3 |
GO:0070086 | ubiquitin-dependent endocytosis | 7.034182e-3 |
GO:0018293 | protein-FAD linkage | 7.034182e-3 |
GO:0045818 | negative regulation of glycogen catabolic process | 7.034182e-3 |
GO:0006121 | mitochondrial electron transport, succinate to ubiquinone | 7.034182e-3 |
GO:0015739 | sialic acid transport | 7.034182e-3 |
GO:0001987 | vasoconstriction of artery involved in baroreceptor response to lowering of systemic arterial blood pressure | 7.034182e-3 |
GO:0032508 | DNA duplex unwinding | 7.118408e-3 |
GO:0072088 | nephron epithelium morphogenesis | 7.336484e-3 |
GO:0061360 | optic chiasma development | 7.369534e-3 |
GO:0035799 | ureter maturation | 7.369534e-3 |
GO:2000597 | positive regulation of optic nerve formation | 7.369534e-3 |
GO:0014053 | negative regulation of gamma-aminobutyric acid secretion | 7.369534e-3 |
GO:0021633 | optic nerve structural organization | 7.369534e-3 |
GO:0021650 | vestibulocochlear nerve formation | 7.369534e-3 |
GO:0005980 | glycogen catabolic process | 7.388419e-3 |
GO:0006659 | phosphatidylserine biosynthetic process | 7.457306e-3 |
GO:0048255 | mRNA stabilization | 7.466617e-3 |
GO:0072028 | nephron morphogenesis | 7.481741e-3 |
GO:0060421 | positive regulation of heart growth | 7.773750e-3 |
GO:0030833 | regulation of actin filament polymerization | 7.908808e-3 |
GO:0060996 | dendritic spine development | 7.942308e-3 |
GO:0006997 | nucleus organization | 7.954359e-3 |
GO:0019987 | negative regulation of anti-apoptosis | 8.001535e-3 |
GO:2000018 | regulation of male gonad development | 8.056959e-3 |
GO:0010824 | regulation of centrosome duplication | 8.056959e-3 |
GO:0071711 | basement membrane organization | 8.093758e-3 |
GO:0030071 | regulation of mitotic metaphase/anaphase transition | 8.374853e-3 |
GO:0006497 | protein lipidation | 8.482919e-3 |
GO:0035176 | social behavior | 8.506234e-3 |
GO:0051299 | centrosome separation | 8.627411e-3 |
GO:0042402 | cellular biogenic amine catabolic process | 8.673902e-3 |
GO:0045980 | negative regulation of nucleotide metabolic process | 8.799677e-3 |
GO:0035414 | negative regulation of catenin import into nucleus | 8.965705e-3 |
GO:0003339 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 9.034779e-3 |
GO:0015807 | L-amino acid transport | 9.046010e-3 |
GO:0003337 | mesenchymal to epithelial transition involved in metanephros morphogenesis | 9.056538e-3 |
GO:0060539 | diaphragm development | 9.092176e-3 |
GO:0032392 | DNA geometric change | 9.092176e-3 |
GO:0046125 | pyrimidine deoxyribonucleoside metabolic process | 9.340664e-3 |
GO:0035855 | megakaryocyte development | 9.385603e-3 |
GO:0050658 | RNA transport | 9.450787e-3 |
GO:0006333 | chromatin assembly or disassembly | 9.450787e-3 |
GO:0051292 | nuclear pore complex assembly | 9.537896e-3 |
GO:0010735 | positive regulation of transcription via serum response element binding | 9.537896e-3 |
GO:2000277 | positive regulation of oxidative phosphorylation uncoupler activity | 9.537896e-3 |
GO:0003221 | right ventricular cardiac muscle tissue morphogenesis | 9.537896e-3 |
GO:0003406 | retinal pigment epithelium development | 9.537896e-3 |
GO:0006438 | valyl-tRNA aminoacylation | 9.537896e-3 |
GO:0034551 | mitochondrial respiratory chain complex III assembly | 9.571050e-3 |
GO:0008611 | ether lipid biosynthetic process | 9.571050e-3 |
GO:0061034 | olfactory bulb mitral cell layer development | 9.622473e-3 |
GO:0090398 | cellular senescence | 9.708280e-3 |
GO:0030032 | lamellipodium assembly | 9.793503e-3 |
GO:0042254 | ribosome biogenesis | 9.953358e-3 |
GO:0051382 | kinetochore assembly | 1.004239e-2 |
GO:0007341 | penetration of zona pellucida | 1.023078e-2 |
GO:0010498 | proteasomal protein catabolic process | 1.072284e-2 |
GO:0072078 | nephron tubule morphogenesis | 1.072664e-2 |
GO:0072182 | regulation of nephron tubule epithelial cell differentiation | 1.075369e-2 |
GO:2000275 | regulation of oxidative phosphorylation uncoupler activity | 1.078975e-2 |
GO:0021670 | lateral ventricle development | 1.108501e-2 |
GO:0051882 | mitochondrial depolarization | 1.112196e-2 |
GO:0051684 | maintenance of Golgi location | 1.112196e-2 |
GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore | 1.112196e-2 |
GO:0031860 | telomeric 3' overhang formation | 1.112196e-2 |
GO:0042450 | arginine biosynthetic process via ornithine | 1.112196e-2 |
GO:0019676 | ammonia assimilation cycle | 1.112196e-2 |
GO:0002031 | G-protein coupled receptor internalization | 1.132410e-2 |
GO:0090185 | negative regulation of kidney development | 1.137498e-2 |
GO:0008608 | attachment of spindle microtubules to kinetochore | 1.137498e-2 |
GO:0008064 | regulation of actin polymerization or depolymerization | 1.150184e-2 |
GO:0045654 | positive regulation of megakaryocyte differentiation | 1.150216e-2 |
GO:0072500 | negative regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor | 1.156899e-2 |
GO:0060084 | synaptic transmission involved in micturition | 1.156899e-2 |
GO:0019060 | intracellular transport of viral proteins in host cell | 1.156899e-2 |
GO:0046967 | cytosol to ER transport | 1.156899e-2 |
GO:0048697 | positive regulation of collateral sprouting in absence of injury | 1.156899e-2 |
GO:2000053 | regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification | 1.203271e-2 |
GO:0035087 | siRNA loading onto RISC involved in RNA interference | 1.203283e-2 |
GO:0031118 | rRNA pseudouridine synthesis | 1.203283e-2 |
GO:0070830 | tight junction assembly | 1.207644e-2 |
GO:2000381 | negative regulation of mesoderm development | 1.221316e-2 |
GO:0007141 | male meiosis I | 1.247994e-2 |
GO:0033002 | muscle cell proliferation | 1.251513e-2 |
GO:0006457 | protein folding | 1.264537e-2 |
GO:0003195 | tricuspid valve formation | 1.270456e-2 |
GO:0001955 | blood vessel maturation | 1.326849e-2 |
GO:0035802 | adrenal cortex formation | 1.332755e-2 |
GO:2000173 | negative regulation of branching morphogenesis of a nerve | 1.333742e-2 |
GO:0042758 | long-chain fatty acid catabolic process | 1.333742e-2 |
GO:0003094 | glomerular filtration | 1.333742e-2 |
GO:0042413 | carnitine catabolic process | 1.333742e-2 |
GO:0071673 | positive regulation of smooth muscle cell chemotaxis | 1.356116e-2 |
GO:0032203 | telomere formation via telomerase | 1.356116e-2 |
GO:0016567 | protein ubiquitination | 1.372203e-2 |
GO:0045738 | negative regulation of DNA repair | 1.372290e-2 |
GO:0035507 | regulation of myosin-light-chain-phosphatase activity | 1.372290e-2 |
GO:0043084 | penile erection | 1.372290e-2 |
GO:0051321 | meiotic cell cycle | 1.393890e-2 |
GO:0060263 | regulation of respiratory burst | 1.400855e-2 |
GO:0016601 | Rac protein signal transduction | 1.409047e-2 |
GO:0032757 | positive regulation of interleukin-8 production | 1.446939e-2 |
GO:0009084 | glutamine family amino acid biosynthetic process | 1.453936e-2 |
GO:0071526 | semaphorin-plexin signaling pathway | 1.458965e-2 |
GO:0006284 | base-excision repair | 1.465785e-2 |
GO:0022616 | DNA strand elongation | 1.538901e-2 |
GO:0021678 | third ventricle development | 1.545526e-2 |
GO:0003175 | tricuspid valve development | 1.574556e-2 |
GO:0060231 | mesenchymal to epithelial transition | 1.600611e-2 |
GO:0033133 | positive regulation of glucokinase activity | 1.607627e-2 |
GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine | 1.610877e-2 |
GO:0050779 | RNA destabilization | 1.641063e-2 |
GO:0001672 | regulation of chromatin assembly or disassembly | 1.641063e-2 |
GO:0032271 | regulation of protein polymerization | 1.652976e-2 |
GO:0034393 | positive regulation of smooth muscle cell apoptosis | 1.654827e-2 |
GO:0006513 | protein monoubiquitination | 1.655235e-2 |
GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I | 1.685320e-2 |
GO:0043161 | proteasomal ubiquitin-dependent protein catabolic process | 1.695282e-2 |
GO:0006568 | tryptophan metabolic process | 1.711992e-2 |
GO:0072195 | kidney smooth muscle cell differentiation | 1.731885e-2 |
GO:0031247 | actin rod assembly | 1.731885e-2 |
GO:0072105 | ureteric peristalsis | 1.731885e-2 |
GO:0045454 | cell redox homeostasis | 1.737309e-2 |
GO:0034435 | cholesterol esterification | 1.749904e-2 |
GO:0072208 | metanephric smooth muscle tissue development | 1.762519e-2 |
GO:0072184 | renal vesicle progenitor cell differentiation | 1.762519e-2 |
GO:0090094 | metanephric cap mesenchymal cell proliferation involved in metanephros development | 1.762519e-2 |
GO:0072259 | metanephric interstitial cell development | 1.762519e-2 |
GO:0035674 | tricarboxylic acid transmembrane transport | 1.762519e-2 |
GO:0072169 | specification of posterior mesonephric tubule identity | 1.762519e-2 |
GO:0060061 | Spemann organizer formation | 1.762519e-2 |
GO:0072168 | specification of anterior mesonephric tubule identity | 1.762519e-2 |
GO:0046605 | regulation of centrosome cycle | 1.778692e-2 |
GO:0033108 | mitochondrial respiratory chain complex assembly | 1.778692e-2 |
GO:0060075 | regulation of resting membrane potential | 1.790147e-2 |
GO:0051016 | barbed-end actin filament capping | 1.790147e-2 |
GO:0052312 | modulation of transcription in other organism involved in symbiotic interaction | 1.807850e-2 |
GO:0022613 | ribonucleoprotein complex biogenesis | 1.833743e-2 |
GO:0045963 | negative regulation of dopamine metabolic process | 1.853470e-2 |
GO:0034421 | post-translational protein acetylation | 1.853470e-2 |
GO:0050668 | positive regulation of homocysteine metabolic process | 1.853470e-2 |
GO:0030421 | defecation | 1.853470e-2 |
GO:0015746 | citrate transport | 1.853470e-2 |
GO:0033572 | transferrin transport | 1.853470e-2 |
GO:0001678 | cellular glucose homeostasis | 1.892910e-2 |
GO:0009211 | pyrimidine deoxyribonucleoside triphosphate metabolic process | 1.910951e-2 |
GO:0090161 | Golgi ribbon formation | 1.910951e-2 |
GO:0070189 | kynurenine metabolic process | 1.916561e-2 |
GO:0042771 | DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis | 1.928940e-2 |
GO:0090192 | regulation of glomerulus development | 1.957041e-2 |
GO:0050935 | iridophore differentiation | 1.966406e-2 |
GO:0071281 | cellular response to iron ion | 1.966406e-2 |
GO:0048937 | lateral line nerve glial cell development | 1.966406e-2 |
GO:0007529 | establishment of synaptic specificity at neuromuscular junction | 1.966406e-2 |
GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process | 1.966406e-2 |
GO:0006929 | substrate-dependent cell migration | 2.033792e-2 |
GO:0060691 | epithelial cell maturation involved in salivary gland development | 2.043626e-2 |
GO:0071284 | cellular response to lead ion | 2.043626e-2 |
GO:2000469 | negative regulation of peroxidase activity | 2.043626e-2 |
GO:2000429 | negative regulation of neutrophil aggregation | 2.043626e-2 |
GO:0071638 | negative regulation of monocyte chemotactic protein-1 production | 2.043626e-2 |
GO:0060096 | serotonin secretion, neurotransmission | 2.043626e-2 |
GO:0035726 | common myeloid progenitor cell proliferation | 2.043626e-2 |
GO:0021941 | negative regulation of cerebellar granule cell precursor proliferation | 2.043626e-2 |
GO:0018160 | peptidyl-pyrromethane cofactor linkage | 2.043626e-2 |
GO:0034205 | beta-amyloid formation | 2.043626e-2 |
GO:0060218 | hemopoietic stem cell differentiation | 2.062396e-2 |
GO:0021592 | fourth ventricle development | 2.062396e-2 |
GO:0072189 | ureter development | 2.084172e-2 |
GO:0016568 | chromatin modification | 2.091203e-2 |
GO:0033599 | regulation of mammary gland epithelial cell proliferation | 2.093502e-2 |
GO:0006777 | Mo-molybdopterin cofactor biosynthetic process | 2.095738e-2 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 2.095980e-2 |
GO:0006261 | DNA-dependent DNA replication | 2.110924e-2 |
GO:0043543 | protein acylation | 2.113825e-2 |
GO:0032272 | negative regulation of protein polymerization | 2.156434e-2 |
GO:0032874 | positive regulation of stress-activated MAPK cascade | 2.162121e-2 |
GO:0048880 | sensory system development | 2.187477e-2 |
GO:0039020 | pronephric nephron tubule development | 2.204525e-2 |
GO:0035565 | regulation of pronephros size | 2.204525e-2 |
GO:0031047 | gene silencing by RNA | 2.279267e-2 |
GO:0034260 | negative regulation of GTPase activity | 2.286783e-2 |
GO:0048840 | otolith development | 2.290701e-2 |
GO:2000172 | regulation of branching morphogenesis of a nerve | 2.290701e-2 |
GO:0015870 | acetylcholine transport | 2.290701e-2 |
GO:0015820 | leucine transport | 2.290701e-2 |
GO:0021602 | cranial nerve morphogenesis | 2.315167e-2 |
GO:0015813 | L-glutamate transport | 2.315167e-2 |
GO:0006172 | ADP biosynthetic process | 2.341577e-2 |
GO:0090083 | regulation of inclusion body assembly | 2.363912e-2 |
GO:0072283 | metanephric renal vesicle morphogenesis | 2.395106e-2 |
GO:0009988 | cell-cell recognition | 2.409251e-2 |
GO:0050872 | white fat cell differentiation | 2.456622e-2 |
GO:2000224 | regulation of testosterone biosynthetic process | 2.457301e-2 |
GO:0072368 | regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter | 2.457301e-2 |
GO:0072362 | regulation of glycolysis by negative regulation of transcription from RNA polymerase II promoter | 2.457301e-2 |
GO:0006782 | protoporphyrinogen IX biosynthetic process | 2.457301e-2 |
GO:0060430 | lung saccule development | 2.465806e-2 |
GO:0006414 | translational elongation | 2.466192e-2 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 2.481588e-2 |
GO:0031627 | telomeric loop formation | 2.532804e-2 |
GO:0010661 | positive regulation of muscle cell apoptosis | 2.642142e-2 |
GO:0072234 | metanephric nephron tubule development | 2.646771e-2 |
GO:0072087 | renal vesicle development | 2.646771e-2 |
GO:0061156 | pulmonary artery morphogenesis | 2.676381e-2 |
GO:0000212 | meiotic spindle organization | 2.676381e-2 |
GO:0072210 | metanephric nephron development | 2.682595e-2 |
GO:0051549 | positive regulation of keratinocyte migration | 2.696285e-2 |
GO:0072181 | mesonephric duct formation | 2.756835e-2 |
GO:0051383 | kinetochore organization | 2.756835e-2 |
GO:0006598 | polyamine catabolic process | 2.756835e-2 |
GO:0022007 | convergent extension involved in neural plate elongation | 2.789160e-2 |
GO:0008612 | peptidyl-lysine modification to hypusine | 2.789160e-2 |
GO:0031397 | negative regulation of protein ubiquitination | 2.790014e-2 |
GO:0071843 | cellular component biogenesis at cellular level | 2.806747e-2 |
GO:0043248 | proteasome assembly | 2.809248e-2 |
GO:0010452 | histone H3-K36 methylation | 2.809248e-2 |
GO:0072170 | metanephric tubule development | 2.820339e-2 |
GO:0071168 | protein localization to chromatin | 2.834523e-2 |
GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus | 2.834523e-2 |
GO:0072077 | renal vesicle morphogenesis | 2.870062e-2 |
GO:0006290 | pyrimidine dimer repair | 2.905576e-2 |
GO:0031128 | developmental induction | 2.908085e-2 |
GO:0051769 | regulation of nitric-oxide synthase biosynthetic process | 2.912882e-2 |
GO:0006020 | inositol metabolic process | 2.924253e-2 |
GO:0009207 | purine ribonucleoside triphosphate catabolic process | 2.972805e-2 |
GO:0009185 | ribonucleoside diphosphate metabolic process | 2.973133e-2 |
GO:0051028 | mRNA transport | 2.987150e-2 |